Publicaciones en las que colabora con Joaquim Mullol Miret (30)

2016

  1. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870

2013

  1. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

    Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684

  2. Antihistamines in drivers, aircrew and occupations of risk.

    Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 27-34

  3. Bilastine for the treatment of urticaria

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 11, pp. 1537-1544

  4. ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19

  5. H1 antihistamines and benzodiazepines. Pharmacological interactions and their impact on cerebral function.

    Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 17-26

  6. Use of second generation H1 antihistamines in special situations.

    Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 1-16

2011

  1. Bilastine and quality of life.

    Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Vol. 21 Suppl 3, pp. 16-23

  2. Bilastine and the central nervous system.

    Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Vol. 21 Suppl 3, pp. 9-15

  3. Effect of antihistamine up-dosing in chronic urticaria.

    Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Vol. 21 Suppl 3, pp. 34-39

  4. Effect of bilastine upon nasal obstruction.

    Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Vol. 21 Suppl 3, pp. 2-8

  5. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.

    Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Vol. 21 Suppl 3, pp. 24-33

  6. Placebo effect in clinical trials involving patients with allergic rhinitis.

    Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Vol. 21 Suppl 3, pp. 40-45

  7. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study

    Pediatric Allergy and Immunology, Vol. 22, Núm. 4, pp. 388-392

2010

  1. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 65, Núm. 12, pp. 1609-1613

2009

  1. Allergic conjunctivitis and H1 antihistamines

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 11-18